Table 2 Anthropometric measures for the study’s population.
From: Elevated asprosin in hypertension: evidence from an exploratory case-control study
Variable | Controls | Cases | P value | ||||
|---|---|---|---|---|---|---|---|
Total | Males | Females | Total | Males | Females | ||
BMI | 30.7 (9.5)¥ | 27.7 (5.8)¥#** | 34.1 (6.1)** | 33.2 (6.8) | 32.0 (7.4)# | 34.6 (5.6) | 0.160 |
WC | 101.2 (12.4) | 98.5 (16.5) | 101.0 (12.4) | 105.9 (14.6) | 106.7 (14.9) | 104.9 (14.4) | 0.074 |
BMI categories n (%) | 0.274 | ||||||
Under weight | 0 (0.0) | 0 (0.0)* | 0(0.0)* | 1 (1.8) | 1 (3.2) | 0 (0.0) | |
Normal weight | 5 (9.1) | 4 (15.4)* | 1 (3.4)* | 4 (7.3) | 3 (9.7) | 1 (4.2) | |
Overweight | 22 (40.0) | 14 (53.8)* | 8 (27.6)* | 14 (25.5) | 9 (29.0) | 5 (20.8) | |
Obese | 28 (50.9) | 8 (30.8)* | 20 (69.0)* | 36 (65.4) | 18 (58.1) | 18 (75.0) | |
WC categories n (%) | 0.145 | ||||||
Normal | 20 (36.4) | 15 (57.7)** | 5 (17.2)** | 13 (23.6) | 10 (32.3) | 3 (12.5) | |
Enlarged | 35 (63.6) | 11 (42.3)** | 24 (82.8)** | 42 (76.4) | 21 (67.7) | 21 (87.5) | |
Elevated BMI&WC n (%) | 0.145 | ||||||
No risk | 20 (36.4) | 15 (57.7)** | 5 (17.2)** | 13 (23.6) | 10 (32.3) | 3 (12.5) | |
At risk | 35 (63.6) | 11 (42.3)** | 24 (82.8)** | 42 (76.4) | 21 (67.7) | 21 (87.5) | |